Sugi Predict

Sugi Predict / Compounds / SCHEMBL4773634

SCHEMBL4773634

SCHEMBL4773634

CCCCC1(CCCC)C(=O)[SH]c2cc(OCC(=O)N[C@@H](C(=O)NC(C[S@+](C)[O-])C(=O)O)c3ccc(O)cc3)c(SC)cc2N(c2ccccc2)C1=O

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ NR1H4 Q96RI1 1/20 0.54
▸ KMT2A Q03164 1/20 0.33
▸ ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4846444 0.96 NR1H4 (0.49) NR1H4
SCHEMBL4636187 0.93 NR1H4 (0.62) NR1H4KMT2AATM
SCHEMBL3831828 0.93 NR1H4 (0.56) NR1H4KMT2AATM
SCHEMBL4783638 0.93 NR1H4 (0.56) NR1H4KMT2AATM
SCHEMBL6447798 0.92 NR1H4 (0.56) NR1H4KMT2AATM
SCHEMBL6206446 0.91 NR1H4 (0.55) NR1H4KMT2AATM
SCHEMBL5821358 0.91 NR1H4 (0.56) NR1H4KMT2AATM
SCHEMBL6250345 0.90 NR1H4 (0.52) NR1H4KMT2AATM
SCHEMBL5320529 0.90 NR1H4 (0.55) NR1H4KMT2AATM
SCHEMBL5709249 0.90 NR1H4 (0.56) NR1H4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1877067-A1 4-BIARYLYL-1-PHENYLAZETIDIN-2-ONE GLUCURONIDE DERIVATIVES FOR HYPERCHOLESTEROLEMIA Microbia, Inc. (US) 2008-01-16 — — EP disclosed
WO-2006116499-A1 4-BIARYLYL-1-PHENYLAZETIDIN-2-ONE GLUCURONIDE DERIVATIVES FOR HYPERCHOLESTEROLEMIA MICROBIA, INC. (US) 2006-11-02 — — WO disclosed
EP-1699759-A1 DIPHENYLAZETIDINONE DERIVATES POSSESSING CHOLESTEROL ABSORPTION INHIBITORY ACTIVITY AstraZeneca AB (SE) 2006-09-13 — — EP disclosed
WO-2005061452-A1 DIPHENYLAZETIDINONE DERIVATES POSSESSING CHOLESTEROL ABSORPTION INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2005-07-07 — — WO disclosed